Clinical Trial Results for Idiopathic Short Stature

2 Clinical Trials for Idiopathic Short Stature

Focus your search

RECRUITING
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Description

The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH), in children with idiopathic short stature (ISS).

RECRUITING
A Study to Assess Growth in Children with Idiopathic Short Stature
Description

Study 111-903 will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.